Home>Forschung>Klinische Studien>COATS-VEGF

How to use the speech recognition tool?

NCT03940690

COATS-VEGF

Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease.

Type: Interventional



Status of the trial: Active, Recruiting

Orphan Drug Recognition: NA

Inclusion

  • Opening Date: 2019-10-24
  • Closing Date: 2022-11-01

Criteria

More information

Children: Yes

Adults: No

Funder Type: other

HCP: Principal investigators

HCP: Other investigators

Within ERN-EYE members

Principal investigators



Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe

* indicates required

This ERN is supported by: